Fundraising FoxREVO Oncology Diagnostics
Frisco, US · Founded 2025 · Delaware corporation
Find your way into REVO Oncology Diagnostics
Sign up to see every warm intro you have to REVO Oncology Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the REVO Oncology Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EK
Estevan KiernanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$270K disclosed across 1 round · 2025
▶$270KraisedApr 2026 · 7 investors · Other Health CareRule 506(b)
▶$270KraisedApr 2026 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Estevan KiernanExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $270K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has REVO Oncology Diagnostics raised?
- REVO Oncology Diagnostics has disclosed $270K raised across 1 round.
- Where is REVO Oncology Diagnostics headquartered?
- REVO Oncology Diagnostics is headquartered in Frisco, US.